Table 3 MVP densities: test for association with ordinal clinical, neuropathological and genetic (APOE) variables
From: A neuropathologic feature of brain aging: multi-lumen vascular profiles
MVP Density (#/µm) | Statistical significance | |
|---|---|---|
Demographics, median density (IQR) | ||
Sex | ||
Male | 1.18 (1.34) | NS |
Female | 1.38 (1.31) | |
Neuropathological variables | ||
Atherosclerosis | NS | |
None | 0.82 (0.42) | |
Mild | 1.63 (1.62) | |
Moderate | 1.39 (1.21) | |
Severe | 1.36 (1.29) | |
Almost occluded | 0.97 (0.85) | |
B-ASC | NS | |
None | 0.92 (0.92) | |
Mild | 1.54 (1.17) | |
Moderate | 1.31 (1.60) | |
Severe | 0.80 (NA) | |
Genetic variables | ||
APOE genotype | NS | |
ℇ2/ℇ3 | 1.30 (1.73) | |
ℇ3/ℇ3 | 1.32 (1.01) | |
ℇ3/ℇ4 | 1.19 (1.62) |